Joji Suzuki

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

The American journal on addictions

Open forum infectious diseases

JMIR formative research

Neuromodulation : journal of the International Neuromodulation Society

Brigham and Women's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital Aug 02 2008

United States

Director, Division of Addiction Psychiatry :: Psychiatry

Publications

Sarah Zambrano, Molly L Paras, Joji Suzuki, Jeffrey C Pearson, Brandon Dionne, Harry Schrager, Jason Mallada, Veronica Szpak, Katie Fairbank-Haynes, Marlene Kalter, Sara Prostko, Daniel A Solomon
Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs. Open forum infectious diseases 11 (4) (2024)
Amber N Edinoff, David B Hathaway, David Martinez Garza, Jordan H Rosen, Joji Suzuki
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report. The American journal on addictions 33 (3) (2024)
Amber N Edinoff, David B Hathaway, David Martinez Garza, Jordan H Rosen, Joji Suzuki
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report. The American journal on addictions 33 (3) (2024)
Sarah Zambrano, Molly L Paras, Joji Suzuki, Jeffrey C Pearson, Brandon Dionne, Harry Schrager, Jason Mallada, Veronica Szpak, Katie Fairbank-Haynes, Marlene Kalter, Sara Prostko, Daniel A Solomon
Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs. Open forum infectious diseases 11 (4) (2024)
Amber N Edinoff, David B Hathaway, David Martinez Garza, Jordan H Rosen, Joji Suzuki
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report. The American journal on addictions 33 (3) (2024)
Amber N Edinoff, David B Hathaway, David Martinez Garza, Jordan H Rosen, Joji Suzuki
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report. The American journal on addictions 33 (3) (2024)
Amber N Edinoff, David B Hathaway, David Martinez Garza, Jordan H Rosen, Joji Suzuki
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report. The American journal on addictions 33 (3) (2024)
Sarah Zambrano, Molly L Paras, Joji Suzuki, Jeffrey C Pearson, Brandon Dionne, Harry Schrager, Jason Mallada, Veronica Szpak, Katie Fairbank-Haynes, Marlene Kalter, Sara Prostko, Daniel A Solomon
Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs. Open forum infectious diseases 11 (4) (2024)
Amber N Edinoff, David B Hathaway, David Martinez Garza, Jordan H Rosen, Joji Suzuki
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report. The American journal on addictions (2024)
Amanda Kim, Joji Suzuki
Addiction specialists' attitudes toward psychedelics: A National Survey. The American journal on addictions (2023)
Claudia P Rodriguez, Joji Suzuki
Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended-release buprenorphine. The American journal on addictions (2023)
Joji Suzuki, Frank Loguidice, Sara Prostko, Veronica Szpak, Samata Sharma, Lisa Vercollone, Carol Garner, David K Ahern
Digitally Assisted Peer Recovery Coach to Facilitate Linkage to Outpatient Treatment Following Inpatient Alcohol Withdrawal Treatment: Proof-of-Concept Pilot Study. JMIR formative research 7 (2023)
David B Hathaway, Jasra-Ali Bhat, Claire Twark, Claudia P Rodriguez, Joji Suzuki
Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report. The American journal on addictions (2023)
Michael Hsu, Bianca Martin, Saeed Ahmed, John B Torous, Joji Suzuki
Smartphone Ownership, Smartphone Utilization, and Interest in Using Mental Health Apps to Address Substance Use Disorders: Literature Review and Cross-sectional Survey Study Across Two Sites. JMIR formative research 6 (7) (2022)
Joji Suzuki, Bianca Martin, Sara Prostko, Peter Ray Chai, Roger D Weiss
Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study. Integrative medicine reports 1 (1) (2022)
Michael Butterfield, Lucas Thorne-Humphrey, Joji Suzuki, Nicole Herschenhous
Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients. The American journal on addictions 29 (6) (2020)
Joji Suzuki, Diana Robinson, Matthew Mosquera, Daniel A Solomon, Mary W Montgomery, Christin D Price, Jennifer A Johnson, Bianca Martin, Jane W Liebschutz, Jeffrey L Schnipper, Roger D Weiss
Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. The American journal on addictions 29 (2) (2020)
June-Ho Kim, Danielle R Fine, Lily Li, Simeon D Kimmel, Long H Ngo, Joji Suzuki, Christin N Price, Matthew V Ronan, Shoshana J Herzig
Disparities in United States hospitalizations for serious infections in patients with and without opioid use disorder: A nationwide observational study. PLoS medicine 17 (8) (2020)
Michael Hsu, David K Ahern, Joji Suzuki
Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic. JMIR mental health 7 (10) (2020)
Heather Burrell Ward, Matthew J Mosquera, Joji Suzuki, Timothy Y Mariano
A Systematic Review of Noninvasive Brain Stimulation for Opioid Use Disorder. Neuromodulation : journal of the International Neuromodulation Society 23 (3) (2020)
Saeed Ahmed, Siddhi Bhivandkar, Brady B Lonergan, Joji Suzuki
Microinduction of Buprenorphine/Naloxone: A Review of the Literature. The American journal on addictions 30 (4) (2020)
Heather Burrell Ward, Brian S Barnett, Joji Suzuki
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report. Substance abuse 40 (2) (2019)
Joji Suzuki, Jennifer Johnson, Mary Montgomery, Margaret Hayden, Christin Price
Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature. Open forum infectious diseases 5 (9) (2018)

Joji Suzuki.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joji Suzuki